Cryphonectria (formerly Endothia) parasitica (Murr.) Barr is the causal agent of chestnut blight, responsible for the chestnut decline in many areas of Europe and North America, where very susceptible western Castanea species (C. sativa Mill. and C. dentata Borkh.) are present. 2 The healing and nonlethal cankers discovered on C. sativa in Europe led to the isolation of C. parasitica strains characterized by a reduced virulence when inoculated on susceptible chestnuts. 3, 4 The aim of the present work is either to isolate and characterize secondary metabolites produced by a hypovirulent isolate showing a broad range of vegetative compatibility or to assess their biological activity on selected test plants.
The EtOAc crude extracts obtained from cultures of a hypovirulent strain of C. parasitica designated E13, grown on MPGA, were separated using a series of silica gel chromatography columns and stepwise elution with organic solvents. Four of the several compounds obtained were completely characterized: metabolite 1, a new aromatic acid, along with diaporthin, previously isolated from cultures of virulent strains of C. parasitica, 5 a trace of (+)-orthosporin, 6 and L-p-hydroxyphenyllactic acid (+)-HOPLA, also produced by Candida spp. and various bacterial species. 7 Cryphonectric acid (1) is the metabolite most abundantly produced by E13, representing more than 20% in weight of the crude extract; 1 is a highly polar solid, slightly soluble in organic solvents. Cryphonectric acid 1, isolated as a pale yellow powder, mp >300°C (dec), [R] D +9.2°(c 0.1, MeOH), analyzed for C 15 H 10 O 8 , and the formula was supported by EIMS (M + , 318). Its IR spectrum (KBr) showed bands at 3430 cm -1 (OH) and at 1750 cm -1 , attributable to an ester-like function; the absorption at 1720 cm -1 indicated a further carbonyl function; the UV spectrum (EtOH) showed absorptions at 206, 256, and 293 nm ( 26350, 9600, and 3500). Acetylation of 1 gave the tetraacetate derivative 2, which showed a molecular peak at m/z 486 (EIMS). The 1 H NMR spectrum revealed a broad signal at δ 9.60 (1′-CO 2 H) (two meta-coupled aromatic protons H-4 and -6, J ) 2.0 Hz), of a broad singlet (H-7), which was correlated with an sp 3 oxygen-bearing carbon; also present were two more signals attributable to acetate groups (3′-and 5′-OAc) and to two aromatic protons (H-2′ and -6′), which sharpened by heating at ∼50°C, indicating restricted rotation of the phenyl group about the C(7)-C(4′) bond. The 13 C NMR spectrum gave four acetate signals and two carbonyl signals (C-2 and -7′) and confirmed that one of the two tetrasubstituted aromatic rings has a symmetry axis passing through the C(1′), C(4′) carbons, since C-2′ and -6′ and C-3′ and -5′ presented double intensity.
The relative disposition of substituents around the aromatic rings was deduced along the following lines. The carboxylic moiety was placed at C-1′, since irradiation of H-2′ and -6′ caused the removal of three-bond couplings from C-7′; C-7 was linked to both the aromatic rings since H-7 presented long-range couplings with C-2a, -6, -6a, -3′, -4′, and -5′, while one of the two meta protons was placed at C-6 since it presented mutual NOEs with H-7 (3%). On the basis of these results, the four acetoxy functions were located at C-3, -5, -3′, and -5′ and the C-2 lactone carbon was joined to C-2a to complete the molecular formula of 2. Compound 2 was reacted subsequently with a solution of diazomethane, giving the ester 3. The structure 1 proposed for cryphonectric acid was confirmed by reaction of the fully methylated compound 4 with LAH, to obtain the trihydroxy derivative 6 via the opening of the lactone moiety and the reduction of the two carbonyl ester functions. Long-range coupling of 4.0 Hz between C-6 and H-8 and not between C-6 and H 2 -1 in the corresponding triacetate derivative 7, attributable to a three-bond interaction between the two atoms, placed C-8 at C-7. 8 Finally, the mutual NOEs observed between H-8 and H 2 -1 (Experimental Section) indicated that C-1 and C-8 are ortho-positioned.
As far as the stereochemistry of C-7 is concerned, the CD values of 1 were very low (Experimental Section) and the [R] value changed with time from +9.2°(0 time) to +27.7°(1 day). Moreover in compound 6, CD and [R] values were null; in our opinion the C-7 center must be racemic and the optical activity must be attributed to atropoisomerism around the chirality axis C7-C4′ due to the steric hindrance of the two substituents in the ortho position of ring C. This hypothesis is in agreement with the broadening of the NMR signals of 2, which disappears by heating at ∼50°C. Cryphonectric acid (1) is unusual, but norwedelic acid, a benzofuranic acid isomer of 1, occurs in Wedelia calendulaceae. 9 Metabolites 1, diaporthin, and (()-HOPLA, tested using a tomato seedling bioassay up to 2 mM, did not induce any necrotic symptoms on leaves. However, formation of tomato seedlings was totally inhibited by 100 µM 1 and 200 µM diaporthin, while a 75 and 50% inhibitory effect was observed by using 100 and 10 µM diaporthin, respectively. No root inhibition was detected in the presence of 10 µM 1 and 2 and 0.2 mM (()-HOPLA. In a second bioassay on elongation of subapical segments of maize roots, 2 and 0.2 mM (()-HOPLA determined respectively a 16 and 35% increase in the length of the treated samples, comparing with the control. The results are in agreement with the interference with cell differentiation shown by the culture filtrates of E13 C. parasitica strain on chestnut calli of C. sativa and C. mollissima. 10 Further work is required in order to characterize the physiological effects of the compounds produced by E13 on the cultured cells of both susceptible and resistant Castanea species.
Investigations on the potential angiogenesis inhibition by 1, 11 carried out at two different concentrations, 50 and 12.5 µM, showed neither inhibition of the migration of endothelial cells nor cytotoxicity or morphological differentiation of bovine endothelial cells into capillary-like structures, suggesting that 1 does not represent a potential angiogenic inhibitor.
Experimental Section
General Experimental Procedure. 
